awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38222824-081B6176-5AEC-4575-BEAB-7BBD56943A6C
Q38222824-081B6176-5AEC-4575-BEAB-7BBD56943A6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38222824-081B6176-5AEC-4575-BEAB-7BBD56943A6C
Emerging protein kinase inhibitors for the treatment of non-Hodgkin's lymphoma.
P2860
Q38222824-081B6176-5AEC-4575-BEAB-7BBD56943A6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38222824-081B6176-5AEC-4575-BEAB-7BBD56943A6C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
737abb64b5ca0f8de9f0a36e947c2c554adee69b
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.